Bioavailability of Empagliflozin/Metformin Fixed Dose Combinations (FDCs) in Healthy Chinese Volunteers
Clinical trial NCT02102932 · COMPLETED
Trial details
- NCT number
- NCT02102932
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-01
- Primary completion
- 2014-08-01
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.